Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Microba Life Sciences Limited ( (AU:MAP) ) has issued an update.
Microba Life Sciences Limited has updated the market on changes to its issued capital following the expiry of certain options on its register. The company reported that a total of 3,066,666 options, each exercisable at $0.3242 and due to expire in early and late April 2026, have lapsed without being exercised.
The cessation of these securities marginally reduces the company’s potential diluted share base, as the underlying shares tied to the expired options will no longer be issued. This change streamlines Microba’s capital structure and may slightly alter future dilution expectations for existing shareholders.
The most recent analyst rating on (AU:MAP) stock is a Buy with a A$0.29 price target. To see the full list of analyst forecasts on Microba Life Sciences Limited stock, see the AU:MAP Stock Forecast page.
More about Microba Life Sciences Limited
Microba Life Sciences Limited, listed on the ASX under the code MAP, is an Australian life sciences company. The firm operates in the biotechnology sector, although this notice focuses on its capital structure rather than its specific products or services.
Average Trading Volume: 246,078
Technical Sentiment Signal: Sell
Current Market Cap: A$42.63M
See more data about MAP stock on TipRanks’ Stock Analysis page.